18.26
1.46%
-0.27
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares (BIS) Stock Split History
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares has split its stock 3 times since its initial public offering (IPO). The first stock split occurred on October 05, 2012 with the ratio of 1-for-4, meaning that for 4 shares of BIS owned pre-split, shareholders then owned 1 share. 2 more splits have been implemented since then. The most recent stock split took place on August 18, 2020 on a 1-for-4 basis.
These splits have increased BIS stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Proshares Ultrashort Nasdaq Biotechnology 2 X Shares's total market capitalization.
For more detailed information of Proshares Ultrashort Nasdaq Biotechnology 2 X Shares's stock splits, view the table below:
These splits have increased BIS stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Proshares Ultrashort Nasdaq Biotechnology 2 X Shares's total market capitalization.
For more detailed information of Proshares Ultrashort Nasdaq Biotechnology 2 X Shares's stock splits, view the table below:
BIS stock split list
Date | Split Ratio |
---|---|
2020-08-18 | 1 - for - 4 |
2014-11-06 | 1 - for - 5 |
2012-10-05 | 1 - for - 4 |
Will Proshares Ultrashort Nasdaq Biotechnology 2 X Shares Stock Split in 2024?
The answer will depend on the decisions of the company's managers and market volatility. Proshares Ultrashort Nasdaq Biotechnology 2 X Shares has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when BIS stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Proshares Ultrashort Nasdaq Biotechnology 2 X Shares's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):